NEW
Vyepti

Vyepti

Manufacturer:

Lundbeck

Distributor:

DKSH
/
Four Star
Concise Prescribing Info
Contents
Eptinezumab
Indications/Uses
Prophylaxis of migraine in adults who have at least 4 migraine days per mth.
Dosage/Direction for Use
100 mg by IV infusion every 12 wk. Some patients may benefit from 300 mg IV infusion every 12 wk.
Contraindications
Special Precautions
The medicinal product requires dilution prior to administration. Intended for single use only. It should be inspected visually; do not use if the conc contains visible particulate matter or is cloudy or discoloured (other than clear to slightly opalescent, colourless to brownish-yellow). Gently invert the Vyepti soln for infusion to mix completely. Do not shake. Vyepti soln for infusion must be infused w/in 8 hr. During this time, before infusion, may be stored at room temp (below 25°C) or refrigerated at 2-8°C. If stored at 2-8°C, allow the soln for infusion to warm to room temp prior to infusion. Do not freeze. Infusion administration instructions: Infuse Vyepti 100 mg dose or Vyepti 300 mg dose as prescribed, following dilution of the vial content in a 100 mL bag of 0.9% NaCl for inj, over approx 30 min. Use an IV infusion set w/ a 0.2 or 0.22 micrometer in-line or add-on filter. After the infusion is complete, flush the line w/ 20 mL of 0.9% NaCl for inj. No other medications should be administered through the infusion set or mixed w/ Vyepti. Preferable to avoid use during pregnancy. Safety & efficacy in childn 6-18 yr has not yet been established. No relevant use in childn <6 yr for the prophylaxis of migraine.
Adverse Reactions
Nasopharyngitis, hypersensitivity reactions, fatigue.
Drug Interactions
Eptinezumab is not metabolized by cytochrome P450 enzymes. Therefore, interactions by eptinezumab w/ concomitant medications that are substrates, inducers, or inhibitors of cytochrome P450 enzymes are considered unlikely.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD05 - eptinezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Vyepti conc for soln for infusion 100 mg/mL
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in